DocDollars

Mylan Inc.

PA · United States · Reporting entity ID 100000005518

Total reported 2019–2025
$21.2M
#307 of 2,960 reporting companies — 0% of all reported industry payments
$1.26M in general payments across 898 records, plus $20.0M in research funding across 2,570 records.

How it breaks down

General payments $1,255,249
Research funding $19,975,524

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Mylan Inc. reported $21.2M to US doctors and teaching hospitals from 2019 to 2025, ranking #307 of 2,960 reporting companies. 94% of that was research funding and 6% general payments such as consulting, speaking, food and travel. 898 general payment records and 2,570 research records were filed.

Common questions about Mylan Inc.

How much has Mylan Inc. paid US doctors?

Mylan Inc. reported $21,230,773 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $1,255,249 in general payments, $19,975,524 in research funding.

How does Mylan Inc. rank among drug and device companies?

It ranks #307 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Mylan Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.